Suppression-Replacement Gene Therapy

DELTA-LIKE NON-CANONICAL NOTCH LIGAND 1 ACTIVITY MODULATORS AND USES THEREOF

ABCA4 TRANS-SPLICING MOLECULES

Compositions and methods for immunotherapy

APLNR Modulators and Uses Thereof

CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION

VESICULAR STOMATITIS VIRUSES

THERAPEUTIC AGENTS

TYPE I MEMBRANE PROTEINS HETERODIMERS AND METHODS OF USE THEREOF

CHIMERIC RECEPTOR CONSTRUCTS FOR NK CELLS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

Compositions Containing Protein Loaded Exosome and Methods for Preparing and Delivering the Same

Cell

NOTCH RECEPTORS WITH HINGE DOMAIN

MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS

ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE

MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS

METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR-MACROPHAGES AND USE OF SAME CELLS

COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE

Detection of Co-Occurring Receptor-Coding Nucleic Acid Segments

CHIMERIC TIM4 RECEPTORS AND USES THEREOF

ENHANCING MITOCHONDRIAL-BASED FLOW AND CATABOLISM OF CHOLESTEROL

METHOD FOR IDENTIFYING SUBSTANCE CAPABLE OF AFFECTING AGING

RESCUE STRATEGIES FOR BEST1 LOSS- AND GAIN-OF-FUNCTION MUTATIONS

DSG2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19

Vesicle Targeting Proteins And Uses Of Same

Optimized expression cassettes for gene therapy

ABCA4 TRANS-SPLICING MOLECULES

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD20 IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTORS AND ADAPTORS THEREOF

A BROADLY NEUTRALIZING MOLECULE AGAINST CLOSTRIDIUM DIFFICILE TOXIN B

NUCLEAR PROTEIN TARGETING DEUBIQUITINASES AND METHODS OF USE

BECLIN 2 AND USES THEREOF FOR TREATING CANCER AND NEURODEGENERATIVE DISEASES

COMPOSITIONS AND METHODS FOR TREATING CEREBROSPINAL FLUID DISORDERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

RECEPTORS FOR CYCLIC DINUCLEOTIDES AND METHODS FOR SCREENING AGONISTS OR INHIBITORS THEREOF

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

INCREASED VOLTAGE-GATED SODIUM CHANNEL ALPHA PROTEIN SUBUNIT EXPRESSION THROUGH VIRAL 2A-MEDIATED CO-EXPRESSION OF NAV BETA SUBUNITS

CMV VECTORS AND USES THEREOF

CHIMERIC SENSOR PROTEIN AND METHODS OF USE THEREOF

USING DREADD FOR NEURONAL MODULATION IN TREATING NEURONAL DISEASES

Preparation of therapeutic exosomes using membrane proteins

CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS

METHODS OF TREATING LYSOSOMAL DISORDERS

METHODS AND ANTIBODIES FOR MODULATION OF IMMUNORESPONSE

CHEMOGENETIC RECEPTORS AND METHODS OF MAKING AND USING

NEW OPTOGENETIC TOOL

COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS

Oncolytic viruses for sensitizing tumor cells to killing by natural killer cells

RECEPTOR/HISTIDINE KINASE FUSION CONSTRUCTS AND USES THEREOF

COMPOSITIONS, DEVICES AND METHODS FOR IDENTIFYING, TREATING AND PREVENTING INFECTIOUS DISEASE USING MICROBE-TARGETING MOLECULES

NEOANTIGENS AND METHODS OF THEIR USE

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

POLYPEPTIDE COMPOSITIONS COMPRISING SPACERS

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

NEOANTIGENS AND METHODS OF THEIR USE

BACTERIA BASED PROTEIN DELIVERY

SPHERICAL NUCLEIC ACIDS WITH DENDRITIC LIGANDS

Methods of treating cholangiocarcinoma

BINDING SITE IN TYPE 2 RYANODINE RECEPTOR

MANNOSE RECEPTOR-DERIVED PEPTIDES FOR NEUTRALIZING PORE-FORMING TOXINS FOR THERAPEUTIC USES

BIOSENSORS FOR DETECTING CHANGES IN THE LEVEL OF A NEUROTRANSMITTER IN THE CENTRAL NERVOUS SYSTEM

MAdCAM-1 POLYPEPTIDES AND USES THEREOF

VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER

PURIFICATION MATRICES COMPRISING AAV-BINDING POLYPEPTIDES AND METHODS OF USING THE SAME

SARS-COV-2 THERAPIES

SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)

INDUCIBLE CASPASES AND METHODS FOR USE

Use novel light sensitive channel protein VR 1.0 in preparation of retinal photoreceptor cell degenerative disease drug

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

PROTEIN-BASED PURIFICATION MATRICES AND METHODS OF USING THE SAME

NOVEL MEANS TO PREDICT AND MANIPULATE NMDA RECEPTOR-MEDIATED TOXICITY

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers

Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

MATERIALS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS

NY-ESO-1-CONTAINING ARTIFICIAL ADJUVANT VECTOR CELL FOR USE IN TREATMENT OF CANCER

Targeted Gene Therapies for Pain and Other Neuro-Related Disorders

RECOMBINANT FACTOR VIII PROTEINS

METHOD FOR INDUCING NEURONAL SYNAPSE FORMATION AND MICROBEADS USED IN SAID METHOD

Peptide Conjugated Hydrogel Substrate for the Maintenance and Expansion of Human Pluripotent Stem Cells

USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS

ARTIFICIAL SYNAPSES

VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES

CONTROL AND MODULATION OF THE FUNCTION OF GENE-MODIFIED CHIMERIC ANTIGEN RECEPTOR T CELLS WITH DASATINIB AND OTHER TYROSINE KINASE INHIBITORS

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same

CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS

ALK POLYPEPTIDES AND METHODS OF USE THEREOF

AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT

CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES

PROGRAMMED CELLS FOR TARGETED ARTICULAR CARTILAGE AND BONE REGENERATION

T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer Indications

Methods and Compositions for Modulating Toll-Like Receptor 5 (TLR5) Function

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DISEASE

TOLL-LIKE RECEPTOR 2 AGONISTS AND VACCINES AND USES THEREOF

Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers

NOVEL CELLULAR RECEPTORS AND USES THEREOF

MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS

METHODS FOR GENERATING PRIMARY IMMUNE CELLS

REGULATORY T CELL EPITOPES

COMPOSITIONS AND METHODS FOR TREATING EGFR POSITIVE CANCERS

ADENO-ASSOCIATED VIRAL VECTOR FOR GLUT1 EXPRESSION AND USES THEREOF

MODULAR ASSEMBLY RECEPTORS AND USES THEREOF

STEALTH CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF IN REDUCING CYTOTOXICITY TOWARDS NORMAL CELLS

EPHA3 AND MULTI-VALENT TARGETING OF TUMORS

LDLR VARIANTS AND THEIR USE IN COMPOSITIONS FOR REDUCING CHOLESTEROL LEVELS

ENGINEERED PLATELETS FOR TARGETED DELIVERY OF A THERAPEUTIC AGENT

PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS

COMPOSITIONS, METHODS AND USES COMPRISING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE -1 (TCAP-1) FOR ENHANCING MUSCLE PERFORMANCE

Chimeric antigen receptors against multiple HLA-G isoforms

IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases

IMMUNE CELLS WITH INCREASED GLYCOLYTIC FLUX

Nucleic acid construct that encodes chimeric rhodopsin

USE OF THE CD2 SIGNALING DOMAIN IN SECOND-GENERATION CHIMERIC ANTIGEN RECEPTORS

THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR

NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF

RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG

Binding Members to PD-L1

HUMANIZED ACE2-FC FUSION PROTEIN FOR TREATMENT AND PREVENTION OF SARS-COV-2 INFECTION

Organelle-targeted genetically-encoded voltage indicators and methods of use thereof

Polypeptide and method of producing IMP using the same

Fusion proteins comprising an engineered knottin peptide and uses thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

METHODS AND COMPOSITIONS FOR MODULATING CELLS AND CELLULAR MEMBRANES

USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE

BRI2 BRICHOS DOMAIN FOR DELIVERY OF PROTEINS INTO CNS NEURONS

NOVEL USE

Non-naturally occurring vesicles comprising a chimeric vesicle localization moiety, methods of making and uses thereof

PEPTIDES DERIVED FROM SORTILIN

A METHOD OF DECREASING CONCENTRATION OF TAU (T) PROTEIN AND/OR PHOSPHORYLATED TAU (T) PROTEIN

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

METHODS FOR REDUCING CD36 EXPRESSION

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

MODIFIED NATURAL KILLER CELLS AND METHODS OF USING THE SAME

TISSUE SELECTIVE TRANSGENE EXPRESSION

Composition and Use of Engineered Monoclonal Antibodies Refractory to Tumor Immuno-Suppressive Factors

Antibodies to L-type voltage gated channels and related methods

POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD

GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS

COMPOSITIONS AND METHODS FOR TREATING SLC26A4-ASSOCIATED HEARING LOSS

GENE AND MUTATIONS THEREOF ASSOCIATED WITH SEIZURE AND MOVEMENT DISORDERS

SYSTEM AND METHOD FOR GENE EDITING BY USING ENGINEERED CELL

ANTI-STEAP2 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

BTNL3 PROTEINS, NUCLEIC ACIDS AND ANTIBODIES AND USES THEREOF

DE NOVO DESIGNED ALPHA-HELICAL PROTEIN CHANNELS

CELL SURFACE CONJUGATES AND RELATED CELL COMPOSITIONS AND METHODS

GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA

COMPOSITIONS AND METHODS FOR TREATING GJB2-ASSOCIATED HEARING LOSS

HUMANIZED NOTCH RECEPTORS WITH HINGE DOMAIN

CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS

PROPROTEINS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR REDUCING HOST REJECTION OF ALLOGENEIC CELLS USING SIMIAN ICP47 AND VARIANTS THEREOF

POLYPEPTIDES

Methods and Compositions for the ADAR-Mediated Editing of ABCA4

REPEAT DOSING OF HYPOIMMUNOGENIC CELLS

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM

NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR

COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING THE EFFECTS OF INFECTIONS BY CORONAVIRUSES THAT BIND THE EXTRACELLULAR DOMAIN OF THE ACE2 RECEPTOR

DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD

COMPOSITIONS AND METHODS FOR TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL

DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES

G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING MACULAR DYSTROPHY

GPC3 CAR- T CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

NOVEL PLATFORMS FOR CO-STIMULATION, NOVEL CAR DESIGNS AND OTHER ENHANCEMENTS FOR ADOPTIVE CELLULAR THERAPY

Vectors for Producing Virus-Like Particles and Uses Thereof

Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19

OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY

Multifunctional Heteromultimeric Constructs

IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION AND USE THEREOF

METHODS OF TREATMENT AND NOVEL CONSTRUCTS

METASTASIS INHIBITING PROTEIN

Peptide for cancer immunotherapy rupturing tumor-derived vesicle and use thereof

THERAPEUTIC DELIVERY VESICLES

COMPOSITIONS AND METHODS OF STIMULATING AND EXPANDING T CELLS

NOTCH3 Agonist Compositions and Methods for Treating Small Vessel Diseases

NOVEL THERAPEUTICAL TOOLS AND METHODS USING TEMPERATURE-SENSITIVE RECEPTORS FOR TREATING BLINDNESS

NON-NATURALLY OCCURRING VESICLES COMPRISING A CHIMERIC VESICLE LOCALIZATION MOIETY, METHODS OF MAKING AND USES THEREOF

Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps)

Compositions and methods relating to structural determination of small proteins

Personalized immunotherapy against several neuronal and brain tumors

ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS

POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF

METHOD FOR PREDICTING PRESENCE OR ABSENCE OF AROMA PROPERTIES OR OLFACTORY RECEPTOR ACTIVATION PROPERTIES IN SUBSTANCE

Methods to spatially profile protease activity in tissue and sections

TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS

CANCER GENE THERAPY DRUG

Methods for Identifying Modulators of G Protein-Coupled Receptors

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EXPRESSING CHIMERIC ANTIGEN RECEPTOR

Chimeric antigen receptor and methods of use thereof

Methods and compositions for screening and treating developmental disorders

METHOD FOR PREPARING GENETICALLY-MODIFIED T CELLS WHICH EXPRESS CHIMERIC ANTIGEN RECEPTOR

T-CELL DEATH ASSOCIATED GENE 8 (TDAG8) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES

SPECIFIC HOST FACTOR OF HEPATITIS B VIRUS INFECTION, AND USE THEREOF

PROPROTEINS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR THE TARGETING OF RHODOPSIN

COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES

BONDED NEUROTOXINS

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

METHODS OF TREATING ANAEMIA

Inducible caspases and methods for use

NY-ESO-1-containing artificial adjuvant vector cell for use in treatment of cancer

ARTIFICIAL SYNAPSES

SYSTEMS AND METHODS FOR TARGETING CANCER CELLS

Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereof

IMPROVED ADENO-ASSOCIATED VIRUS-BINDING PROTEIN, METHOD FOR PRODUCING SAME, AND ADENO-ASSOCIATED VIRUS ADSORBENT USING SAME

NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN

CHIMERIC RECEPTOR PROTEINS AND USES THEREOF

COMPOSITIONS AND METHODS FOR GENE REPLACEMENT

Recombinant chimeric protein for selectins targeting

COMPOSITIONS AND USES THEREOF FOR TREATING, PROGNOSING AND DIAGNOSING PULMONARY HYPERTENSION

Fusion protein comprising IL-2 protein and CD80 protein, and use thereof

Fusion protein comprising IL-2 protein and CD80 protein, and use thereof

TMEM59 PROTEIN DIMER OR CHIMERIC EXPRESSION RECEPTOR IMPROVING T CELL FUNCTION

NANO-PERFORATOR HAVING IMPROVED ANTI-VIRAL ACTIVITY

Macrophage CAR (MOTO-CAR) In Immunotherapy

NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

KCNV2 variants and their use

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

BIORECEPTOR MOLECULES, THE USE OF BIORECEPTOR MOLECULES, SENSORS CONTAINING ELECTRODES MODIFIED WITH THE SAID BIORECEPTOR MOLECULES AND THE DETECTION METHOD OF SARS-COV-2 VIRUS

METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS

Personalized immunotherapy against several neuronal and brain tumors

Personalized immunotherapy against several neuronal and brain tumors

ENGINEERED NATURAL KILLER CELLS AND METHODS FOR USING THE SAME IN IMMUNOTHERAPY AND AUTOPHAGY INHIBITON TECHNIQUES

COMPLEMENT INHIBITORS FOR TREATING DRUG-INDUCED COMPLEMENT-MEDIATED RESPONSE

NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

CHIMERIC ANTIGEN RECEPTOR TARGETING CLL1 AND USE THEREOF

COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES

NOVEL RECEPTORS HAVING A FIBRONECTIN REPEAT FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

CHIMERIC NK RECEPTOR AND METHODS FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY ACTIVE RAP1A FROM A VMD2 PROMOTER

BIOMARKERS FOR ANTI-TIGIT ANTIBODY TREATMENT

NOTCH RECEPTORS WITH MINIMAL LINKER

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

Combined Artificial Cell Death/Reporter System Polypeptide for Chimeric Antigen Receptor Cell and Uses Thereof

METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY

TREATMENT OF X-LINKED JUVENILE RETINOSCHISIS

S-LAYER PROTEIN 2D LATTICE COUPLED DETERGENT-FREE GPCR BIOELECTRONIC INTERFACES, DEVICES, AND METHODS FOR USE THEREOF

Cells Highly Sensitive to Clostridial Neurotoxin

T CELL GENE EXPRESSION ANALYSIS FOR USE IN T CELL THERAPIES

PTPRS AND PROTEOGLYCANS IN AUTOIMMUNE DISEASE

PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

PEPTIDE ANTIGENS AND USES THEREOF

ANTIGEN-BINDING AGENTS THAT SPECIFICALLY BIND EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III

AAV VECTORS ENCODING MINI-PCDH15 AND USES THEREOF

METHOD OF DETERMINING OR INFLUENCING THE CHONDROGENIC POTENTIAL OF MESENCHYMAL STROMAL CELLS

Methods of making and using extracellular domain-based chimeric proteins

Chimeric protein and related genic transfer technology

Transmembrane domain derived from human LRRC24 protein

Recombinant herpes simplex virus having modified glycoprotein gH for retargeting and use thereof

RECOMBINANT HERPES SIMPLEX VIRUS FOR MULTIPLE TARGETING AND USE THEREOF

Anti-TMEFF1 antibodies and antibody drug conjugates

Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof

Systems and methods for mechanogenetic functional ultrasound imaging

ENGINEERED T CELLS AND USES THEREFOR

Methods and composition for gene delivery using an engineered viral particle

HV1 modulators and uses

Anti-podocalyxin antibodies and methods of using the same

ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES

FUSION PROTEINS AND USES THEREOF

METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES

BIOMARKERS FOR NON-HODGKIN LYMPHOMAS AND USES THEREOF

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

Efficient delivery of therapeutic molecules to cells of the inner ear

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

CHIMERIC PROTEINS AND METHODS TO SCREEN FOR COMPOUNDS AND LIGANDS BINDING TO GPCRS

COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE

Adeno-associated virus virions for treatment of epilepsy

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Compositions and Methods for Treating Elevated Secretory Activity

NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN

Compositions and methods for treating EGFR positive cancers

GENETICALLY MODIFIED NK CELLS AND USES THEREOF

EGFR AND ROS1 KINASE IN CANCER

IMMUNE CELLS WITH ENHANCED CYTOTOXICITY AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR INDUCING NOTCH SIGNALING IN TUMOR MICROENVIRONMENTS

COVALENT ADAPTOR SYNNOTCH AND CHIMERIC ANTIGEN RECEPTORS (CARS) FOR PROGRAMMABLE ANTIGEN-TARGETING

Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof

SYNTHETIC IMMUNE CELLS AND METHODS OF USE THEREOF

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

BLOOD BIOMARKER AND GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CRTH2 RECEPTOR ANTAGONISTS

MAGNETIC PARTICLE FOR MODULATING ACTIVITY OF CELL